Skip to main content
Skip to content
Case File
kaggle-ho-024576House Oversight

Tax memorandum detailing partnership KUE's treatment of nonrecourse liabilities and distributions

Tax memorandum detailing partnership KUE's treatment of nonrecourse liabilities and distributions The document provides technical tax guidance on partnership allocations, non‑U.S. person withholding, and basis calculations. It mentions no high‑profile individuals, corporations, or government agencies, and offers no concrete leads on financial flows, misconduct, or political influence. While it could be useful for understanding the structure of KUE, it lacks actionable investigative angles. Key insights: Describes how nonrecourse liabilities are treated as deemed cash distributions to partners.; Outlines tax basis adjustments for Limited Partners in KUE.; Details withholding requirements for non‑U.S. persons receiving dividends from U.S. and non‑U.S. subsidiaries.

Date
Unknown
Source
House Oversight
Reference
kaggle-ho-024576
Pages
1
Persons
1
Integrity
No Hash Available

Summary

Tax memorandum detailing partnership KUE's treatment of nonrecourse liabilities and distributions The document provides technical tax guidance on partnership allocations, non‑U.S. person withholding, and basis calculations. It mentions no high‑profile individuals, corporations, or government agencies, and offers no concrete leads on financial flows, misconduct, or political influence. While it could be useful for understanding the structure of KUE, it lacks actionable investigative angles. Key insights: Describes how nonrecourse liabilities are treated as deemed cash distributions to partners.; Outlines tax basis adjustments for Limited Partners in KUE.; Details withholding requirements for non‑U.S. persons receiving dividends from U.S. and non‑U.S. subsidiaries.

Tags

kagglehouse-oversighttaxpartnershipnonrecourse-liabilitieswithholdingnon‑u.s.-persons

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
economic risk of loss, known as “nonrecourse liabilities,” will be treated as a deemed distribution of cash to that Partner. A decrease in a Partner's percentage interest in KUE because of KUE’s issuance of additional limited partner units (“Limited Partner Units"} would decrease such Partner's share of Company nonreccurse liabilities, if any, and thus would resuit in a corresponding deemed distribution of cash. Treatment of In-Kind Distributions. KUE's distribution of property (other than cash) to a Partner generally will not be taxable to the Partner unless the property is a “marketable security” and the exceptions to the requirement for recognition of gain upon distributions of marketable securities do not apply. Marketable securities, for these purposes, include actively traded securities or equity interests in another entity that are readily convertible into or exchangeable for cash or other marketable securities. If the distributed property constitutes a marketable security, the property would be treated as cash and the Partner would recognize gain, but not loss, to the extent described above. Basis of Common LP Units. A Limited Partner will have an initial tax basis for its Common LP Units equal to the amount it paid for the Common LP Units plus its share of Company nonrecourse liabilities, if any. That basis will be increased by the Limited Partner’s share of Company income and by any increases in its share of Company nonrecourse liabilities, if any. That basis will be decreased, but not below zero, by distributions from KUE, by the Limited Partner’s share of KUE losses, by any decrease in its share of Company nonrecourse liabilities, if any, and by its share of Company expenditures that are not deductible in computing KUE’s taxable income and are not required to be capitalized. Limitations on Deductibility of Company Losses. The deduction by a Limited Partner of its share of Company lasses will be limited to the adjusted tax basis in its Common LP Units. Limited Partners should be aware that they could be subject to various other limitations on their ability to deduct their allocable shares of Company losses (or items of deductions). Such limitations include, but are not limited to, those relating to "investment interest" expense under Section 163(d) of the Code, "miscellaneous itemized deductions" under Section 67 of the Code, certain other itemized deductions of high income individuals under Section 68 of the Code, the “at risk” rules under Section 485 of the Code, and the deductibility of capital losses under the Code. Prospective investors should consult their tax advisors with respect to the potential application of such rules to their particular situation. Allocation of income, Gain, Loss, and Deduction. If KUE has a net profit or net loss, its items of income, gain, loss, and deduction will be allocated among the Partners in accordance with the provisions of the Limited Partnership Agreement. Dispositions of Common LP Units — Recognition of Gain or Loss. A Limited Partner will recognize gain or loss on a sale of Common LP Units equal to the difference between the amount realized and the Limited Partner's adjusted tax basis for the Common LP Units sold. A Limited Partner's amount realized will be measured by the sum of cash or the fair market value of other property received plus its share of Company nonrecourse liabilities, if any. Generally, gain or loss recognized by a Limited Partner on the sale or exchange of Common LP Units will be taxable as capital gain or loss and as long-term capital gain or loss if the Common LP Units were held for more than twelve months. Non-U.S. Persons Withholding. Ownership of Common LP Units by non-U.S. Persons raises special U.S. federal income tax considerations. To the extent that KUE receives dividends from a U.S. subsidiary, distributions of such dividend income to Limited Partners who are non-US. Persons will be subject to U.S. withholding at a rate of 30%, Certain countries have tax treaties with the U.S. that reduce or eliminate the withholding requirement. To fhe extent that KUE receives dividends from a non-U.S. subsidiary, distributions of such dividend income to Limited Partners who are non-U.S. Persons will not be subject to U.S. tax, unless such income were deemed to be effectively connected with a trade or business conducted by KUE in the U.S. KUE will be required to pay withholding tax with respect to the portion of KUE’s income that is “effectively connected” with the conduct of a U.S. trade or business and which is allocable to non-U.S. Persons. Any amounts KUE is required to remit to taxing authorities will be treated as a distribution to the Partner on whose behalf the withholding is being paid and will be charged against current and/or future 143

Related Documents (6)

House OversightUnknown

Industry overview of Curaleaf, CV Sciences, Elixinol, and Green Thumb Industries CBD product lines (Feb 2019)

Industry overview of Curaleaf, CV Sciences, Elixinol, and Green Thumb Industries CBD product lines (Feb 2019) The passage provides a market‑focused summary of several publicly traded cannabis/MSO companies and their product expansions. It contains no specific allegations, financial flows, or connections to high‑level officials, but it does mention revenue figures and growth rates that could be useful for baseline industry analysis. Because it lacks any reference to powerful actors, controversial actions, or actionable leads, its investigative value is limited. Key insights: Curaleaf launched a CBD line sold in 47 states, targeting pharmacy chains and grocery stores.; Curaleaf reported ~$45 M revenue for FY9M18 with 247% YoY growth and 57% gross margin.; CV Sciences’ PlusCBD Oi! brand generated ~$34 M revenue FY9M18, 153% YoY growth, 72% gross margin.

1p
House OversightUnknown

Tax Guidance on Converting Hedge Fund Partnerships to C Corporations After 2018 Tax Reform

Tax Guidance on Converting Hedge Fund Partnerships to C Corporations After 2018 Tax Reform The document outlines potential tax planning strategies for investment managers following the 2018 corporate tax rate reduction. It mentions no specific individuals, firms, or illicit activity, offering only generic guidance that is already public and unlikely to generate controversy or actionable investigative leads. Key insights: New 21% corporate tax rate creates incentive for partnership entities to convert to C corporations.; Conversion deadline for S corporation status may be March 15, 2018.; IRS anti‑abuse rules (accumulated earnings tax, personal holding company tax) could become enforcement focus.

1p
DOJ Data Set 9OtherUnknown

From: Tom Sze

2p
House OversightUnknown

Ares Management SOTP Valuation Exhibit – Financial Projections

Ares Management SOTP Valuation Exhibit – Financial Projections The passage contains only internal valuation tables and financial metrics for Ares Management, with no mention of individuals, transactions, or potential misconduct. It offers no investigative leads. Key insights: Provides projected pre‑tax and after‑tax core FRE per share for 2018.; Shows various valuation multiples and implied share price scenarios.; Cites Morgan Stanley and Thomson Reuters data sources.

1p
DOJ Data Set 9OtherUnknown

From: "Silvina Royston" <MI=IMM>

2p
House OversightOtherNov 11, 2025

Market Overview of Publicly Traded Cannabis Companies Across U.S., Canadian, and Australian Exchanges

The passage provides aggregate financial data on cannabis‑related publicly traded firms and outlines exchange listing requirements. It contains no specific allegations, names, transactions, or links t Most cannabis companies trade on OTC in the U.S. due to lax regulations. Canadian exchanges (TSX, TSXV, CSE) have varying listing standards. CSE permits U.S. cannabis operations, unlike TSX/TSXV.

1p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.